Navigation Links
Prism Glasses Expand the View for Patients with Hemianopia
Date:5/12/2008

Schepens study opens way for high-power permanent version of the glasses

and larger new study

BOSTON, May 12 /PRNewswire/ -- Innovative prism glasses can significantly improve the vision and the daily lives of patients with hemianopia, a condition that blinds half the visual field in both eyes. The peripheral prism glasses, which were invented by Dr. Eli Peli, a Senior Scientist at Schepens Eye Research Institute, were evaluated in the first community-based multi- center trial of such a device, which is published in the May issue of the Archives of Ophthalmology. The study was coordinated by Dr. Alex Bowers, a Senior Scientific Associate at the Institute.

"This is the first real breakthrough in the rehabilitation of patients with this condition," says Peli, a world-renowned low vision expert, the Moakley Scholar in Aging Eye Research at Schepens and a Professor of Ophthalmology at Harvard Medical School. Peli had searched for a solution for his hemianopia patients for many years before designing the peripheral prism glasses, creating a prototype in his laboratory.

More than a million Americans suffer from hemianopia, which blinds the vision in one half of the visual field in both eyes, resulting from damage to the optic pathways in the brain. Most commonly caused by strokes, it can also be the result of brain damage from tumors or trauma. A patient with this condition may be unaware of what he or she cannot see and frequently bumps into walls, trips over objects or walks into people on the side where the visual field is missing.

Peli's goal was to find a way to expand the visual field. He did this by attaching small, specially designed high power prisms on the top and bottom of one spectacle lens, leaving the center of the lens untouched. The prisms pull in images missing from the visual field above and below the line of sight on the side of the vision loss, and alert the patient to the presence of a pot
'/>"/>

SOURCE Schepens Eye Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
2. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
3. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
4. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
5. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
6. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
7. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. PAREXEL Expands Global Clinical Pharmacology Capabilities
10. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
11. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Philips Respironics applauds the efforts of the Ce...raise awareness about an important public health i...ease of the first-ever government study to monitor...milestone in quantifying the size and scope of the... leader and sleep therapy manufacturer, Philips Re...
(Date:11/6/2009)...- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ...0, 2009 at 8:30 a.m. EST to discuss the third quar...r the remainder of 2009. Ron Bentsur, Chief Execu...Keryx will announce its financial results for this...he call. ,, In order to participate in the conf...
(Date:11/6/2009)... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ("...armaceutical company developing human vaccines for...Virus) and other infectious agents, today announce...vided an operational update. ,, Robert McNally,...ented, "We are pleased with our progress during th...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8CeloNova First to Produce Super Sized Embolic Microsphere 60430 1CeloNova First to Produce Super Sized Embolic Microsphere 60430 2Osteotech Announces Third Quarter 2009 Financial Results Release and Conference Call 14668 1Surgery Illness Not Linked to Mental Decline in Seniors 60429 1Surgery Illness Not Linked to Mental Decline in Seniors 60429 2
...h non-valvular,atrial fibrillation receiving eithe...vestigational oral Factor Xa inhibitor, experience...hose taking warfarin, according to new,Phase II da...he American,Society of Hematology in San Francisco...se II clinical study evaluating an oral Factor Xa ...
...carisbamate, an,investigational compound recently ... partial onset seizures (POS) in patients 16 years...poster sessions of the 32nd Annual,Meeting of the ...o identical placebo-controlled clinical trials,inv...f carisbamate as an,adjunctive treatment for patie...
Other Medicine Technology:New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 2New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 3New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 4New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 5Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 2Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 3Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 4Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 5
(Date:11/8/2009)... AARP Praises House Passage of Health Care Reform...n Medicare, improve coverage for all Americans ,...re/ -- ,, SUMMARY: Last night the United Sta...h care reform legislation that would strengthen Me...ance companies that prices millions of Americans o...
(Date:11/8/2009)... WASHINGTON, Nov. 8 Spe...ess conference following the House passage of H.R.... The bill passed by a vote of 220 to 215. Below ...ome of my colleagues just received a call from the...gratulating us on a great victory for the American...
(Date:11/8/2009)... Men’s Health Network (M...ealth risks, especially those linked to exposure t...military service. Bladder cancer is one of those c...s, especially those who once smoked or currently s...gton DC (PRWEB) November 8, 2009 -- Men’s He...
(Date:11/8/2009)... WASHINGTON, Nov. 7 USA...e Health Care for America Act, which will make hea...ance companies accountable and increase access to ...blic option. ,, "Teddy Roosevelt, FDR and Harry...ector Alan Charney. "Today,s vote ranks among our ...
(Date:11/8/2009)... Health Care Vote Shows Who Sides With Working Fa...Pa., Nov. 8 On the heel...epresentatives for a good, balanced health care re...coring of how our state,s U.S. representatives vot...ica Act. ,, The legislation, which passed Satu...
Breaking Medicine News(10 mins):Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2
...ng to the study conducted by Jennifer D. Thomas, a...e University it was found that alcohol exposure re...These kids develop fetal alcohol spectrum disorder...ssion symptoms, abnormal brain wave activity, fra...
...earch conducted by the scientist at the Monell Che...ism behind the detection of sweet// taste by human... saccharin used in high concentration it losses it...e mouth with water, resulting in the aftertaste ex...
...est figures compiled by National AIDS Control Orga... data collection strategy, have shown that an esti...th HIV. This clearly indicates that the number of ...ed by the deadly virus. It is estimated 38% of fem...
... Sally Field was just short of another milestone, ... had been diagnosed with Osteoporosis.//Osteoporos...inning of the bones which enhances the risk of bon...we are young is faster than bone loss. But this pr...
...ng to Libyan officials the five Bulgarian nurses a...eds of Libyan children with HIV will face a new tr...an foreign ministry said the trial in Libya would ...ere tortured into confessing. The allegation...
...t Coordinator Jan Vandemoortele and Lt. Gen. Nadee...n and Reconstruction Authority (ERRA) has announce...from the devastating earthquake. The new plan for ...itation system, skill training, teachers training ...
Other Medicine News:Health News:Alcohol Intake During Pregnancy Is Bad For The Baby’s Hear 2Health News:Understanding how humans detect sweet taste 2Health News:HIV/AIDS On The Rise In India 2Health News:Make No Bones About It: Actress Sally, Fields Osteoporosis Like A star! 2
Thru-The-Lens Headlight/Video Camera System
Maxenon Xi 300
TrueView Sport
TrueView Classic
Medicine Products: